معرفی
Andrea Malaspina serves as Honorary Professor of Neurology at Queen Mary University of London's Blizard Institute within the Faculty of Medicine and Dentistry. He holds dual clinical-academic roles as Consultant Neurologist at Barts Health and Basildon University Hospital since 2001, and Co-Director of the Barts Health MND Care and Research Centre founded in 2009. His leadership extends to the Neurodegeneration Research Group at the Blizard Institute and MND Research Directorship for DeNDRoN and CRN North-Thames.
Education:
- MD cum Laude, University of Pavia (1991)
- PhD in Molecular Neurobiology, Imperial College London
Professor Malaspina's research centers on neurodegenerative and neuroinflammatory pathologies with primary focus on motor neuron disease. His multidisciplinary approach integrates clinical neurology with molecular neuroscience to identify biomarkers and therapeutic targets, particularly examining phenotypic heterogeneity in ALS progression. The group employs longitudinal bio-sampling and innovative room-temperature storage techniques to track disease mechanisms across tissues and biological fluids.
His publication portfolio demonstrates consistent focus on ALS biomarker discovery, with recent work emphasizing neurofilament light chain validation, tissue-fluid proteomic correlations, and phenotypic stratification. Key themes include molecular signatures of disease initiation/progression, immune-metabolic interactions, and translational applications for clinical trial design.
Through the AMBRoSIA, MIROCALS, and ALS Biomarkers Study initiatives, Malaspina has established UK-wide and international collaborations for biomarker resource development. His supervisory record includes multiple PhD students and postdoctoral researchers working on neuromuscular disorders, while educational contributions span MBBS teaching, intercalated BSc programs, and the MSc Neuroscience curriculum.
The Neurodegeneration Research Group maintains active partnerships with the Motor Neuron Disease Association and pharmaceutical industry, with monthly 'Biomarkers and Mechanisms' seminars and annual Blizard Neuromuscular Symposia facilitating knowledge exchange. Patient-centered research design remains integral through public involvement initiatives coordinated with MND Association.
